Clinical Trial Update: Phase II Study of THDBH120 Injection in Overweight or Obese Subjects [Phase 2]

View source ↗

Summary

This document describes a Phase II clinical trial evaluating THDBH120 Injection in adults with overweight or obesity; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• THDBH120 Injection

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Overweight or Obese | Phase 2 | Status: RECRUITING